Aura Biosciences (AURA)

• Market cap: $428M
• 1 day: 13.47%
• 5 days: 19.93%
• 1 month: 28.38%
• 3 months: 9.06%
• 6 months: 7.15%
• Year to date: 27.17%
• 1 year: -10.61%
• 5 years: -54.46%
• 10 years: -54.46%
• Sector: Healthcare
• Industry: Biotechnology

About: Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Employees: 106